Skip to main content
. 2025 Jan 24;16(1):99240. doi: 10.5306/wjco.v16.i1.99240

Table 3.

Hazard ratios (95%CIs) for all-cause mortality between new users of proton pump inhibitors compared to histamine 2 receptor antagonists in a secondary analysis

Outcome
PPI-users
(n = 44834)
H2RA-users
(n = 44834)
HR (95%CI)
At 1-year 8393 7980 1.51 (1.41-1.69)
At 2-years 12950 11989 1.16 (1.04-1.39)
Overall outcome during follow-up 18304 17146 1.17 (1.05-2.16)

PPI: Proton pump inhibitor; HR: Hazard ratio; H2RA: Histamine2 receptor antagonist.